Abstract:Abstract DICER1, an endoribonuclease required for microRNA (miRNA) biogenesis, is essential for embryogenesis and development of many organs including ovary. Germline truncating mutations in DICER1 are seen in families with the pleuropulmonary blastoma-family tumour and dysplasia syndrome. These individuals have a propensity to develop ovarian Sertoli-Leydig cell tumors (SLCTs), a rare class of sex-cord stromal cell tumors that occur in young female. We have recently identified hotspot somatic mutations in RNase IIIb domain (simplified as ‘hotspot mutations’ thereafter) of DICER1 in half of SLCTs. These hotspot mutations impaired IIIb cleavage activity of DICER1 in in vitro cleavage assay and caused a global abolishment of 5p-miRNAs and a partial reduction of 3p-miRNAs in mouse embryonic stems cells expressing ectopic mutant DICER1. However, whether the miRNA biogenesis defect occurs in tumor samples and how DICER1 hotspot mutations promote tumorigenesis are largely unknown. By reviewing the histological features of ovarian SLCTs, we observed a strong correlation between DICER1 hotspot mutation and ovairain SLCTs with retiform pattern, which is often malignant with worse prognosis. Using Illumina small RNA sequencing technology and Exiqon miRNA realtime qPCR, we reported that the global expression of 5p-miRNAs was dramatically reduced in ovarian SLCTs carrying DICER1 hotspot mutations compared to their counterparts without DICER1 hotspot mutation. Although the 3p-miRNAs were largely unaffected, a subset of 3p-miRNAs was significantly increased in ovarian SLCTs with DICER1 hotspot mutations. To address the impact of DICER1 mutation on cell fate, we examined the gene expression profile in SLCTs using Illumina DASL whole transcriptome analysis followed by validation with Nanostring nCounter system. The miRNA production defect was associated with deregulation of genes governing cell fate determination in ovary, such as CYP19A1 (aromatase), FOXL2, FST, FGF9 and FGFR2, and genes that are targets of let-7, such as HMGA2, DICER1, ARID3A and CDC25A. Accordingly, knockin of DICER1 hotspot mutation in SVOG3e cells (immortalized human granulosa cells) led to altered miRNA biogenesis and deregulated expression of genes crucial for ovarian gonadal genesis and cellular transformation. SVOG3e Cells expressing DICER1 hotspot mutation grew faster than those with wildtype DICER1, which was at least partially due to loss of let-7 expression because inhibition of let-7 function by a miRNA sponge also accelerated cell growth. Furthermore, we also showed that loss of function of RNase IIIa domain of DICER1 had similar effect on cell proliferation as wildtype DICER1. Taken together, our data revealed that the hotspot somatic mutations of DICER1 in RNase IIIb domain cause systemic loss of 5p-miRNAs and selective upregulation of some 3p-miRNAs to drive pseudo-differentiation of testicular elements in ovary and cause oncogenic transformation. Thus, our current study sheds lights on the oncogenic potential of DICER1 hotspot mutations in tumor development and sets the stage for developing effective treatment method for malignant ovarian SLCTs. Citation Format: Yemin Wang, Jiamin Chen, Winnie Yang, Janine Senz, Michael S. Anglesio, Blake Gilks, Gregg B. Morin, David G. Huntsman. The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors [abstract]. In: Proceedings of the 10th Biennial Ovarian Cancer Research Symposium; Sep 8-9, 2014; Seattle, WA. Philadelphia (PA): AACR; Clin Cancer Res 2015;21(16 Suppl):Abstract nr POSTER-BIOL-1349.

Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.

Discovery and Validation of Novel Biomarkers for Detection of Cervical Cancer

Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features

Establishment and Validation of a Novel Disulfidptosis-Related Immune Checkpoint Gene Signature in Clear Cell Renal Cell Carcinoma.

Sertoli-Leydig cell tumor with DICER1 mutation

Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.

Sertoli–Leydig tumor and DICER1 gene mutation: A case series and literature review

Abstract POSTER-BIOL-1349: The oncogenic role of DICER1 RNase IIIb domain mutations in ovarian sertoli-leydig cell tumors

Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of DICER1 syndrome

Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors

Diagnostic, prognostic, and immunological roles of CDSN in ovarian cancer

Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries

Itraq-2dlc-Esi-Ms/Ms Based Identification of A New Set of Immunohistochemical Biomarkers for Classification of Dysplastic Nodules and Small Hepatocellular Carcinoma

Identification Of A Potential Ovarian High-Grade Serous Cancer Stem Cell Marker And Its Clinicopathological Associations

Identification and Analysis of Gene Biomarkers for Ovarian Cancer

Characterization and Clinical Significance of the CADM1/HER2/STAT3 Axis in Serous Ovarian Tumors.

Clinicians Practicing Obstetrics and Gynecology Are Uniquely Situated to Recognize DICER1 Syndrome

CLIC1 a Novel Biomarker of Intraperitoneal Metastasis in Serous Epithelial Ovarian Cancer

Aneuploidy Landscape in Precursors of Ovarian Cancer

DICER1-sarcomas of GYN tract: Expanding on an emerging entity

Evaluation of Sirtuin1 Overexpression by Immunohistochemistry in Cervical Intraepithelial Lesions and Invasive Squamous Cell Carcinoma